HomeMedical Devices

Medical Devices Market Research Reports & Consulting

discount on Mnm

Market Reports


Title Published Price TOC Available

Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Management), Application (Knee, Hip, Shoulder), End User (Hospitals, Ambulatory Surgery Centers & Clinics) - Global Forecast to 2022

The global arthroscopy instruments market is projected to reach USD 5.61 Billion by 2022 from USD 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period. The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. The major players of the arthroscopy instruments market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India).

February 2018 $ 5650 selected

Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022

The global defibrillators market is expected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1% during the forecast period. Factors such as technological advancements in defibrillators, increasing burden of target diseases, growing focus on providing public-access defibrillators, and rising number of training & awareness programs on defibrillators are driving the growth of this market. The key players in the defibrillators market include Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Koninklijke Philips N.V. (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).

February 2018 $ 5650 selected

RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) - Global Forecast to 2022

The global RSV diagnostics market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).

February 2018 $ 5650 selected

Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022

The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostic products globally. The major players of the point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), AccuBioTech (China), and Trinity Biotech (US).

February 2018 $ 5650 selected

Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) - Global Forecast to 2023

The global embolic protection devices market is projected to reach USD 604.9 Million by 2023 from USD 405.5 Million in 2018, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period. The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

February 2018 $ 5650 selected

Microplate Systems Market by Product (Microplate Reader (Multi-mode {Hybrid}, Single-mode), Dispenser, Software), Application (Research, Clinical Diagnostics) & End User (Biotechnology, Pharmaceutical, Hospital, Diagnostic Labs) - Forecast to 2022

The global microplate systems market is expected to reach USD 996.9 Million by 2022 from USD 820.3 Million in 2017 at a CAGR of 4.0%. The microplate systems market is highly competitive with the presence of several small and big players. Prominent players in this market include BioTek (US), Danaher (US), PerkinElmer (US), Tecan (Switzerland), Thermo Fisher (US), BMG LABTECH (Germany), BERTHOLD (Germany), Agilent (US), Bio-Rad (US), Promega (US), Biochrom (UK), Corning (US), Lonza (Switzerland), Rayto (China), and Mindray (China).

February 2018 $ 5650 selected

Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022

The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).

February 2018 $ 5650 selected

Intraocular Lens Market by Type (Traditional/Monofocal (Spheric, Aspheric), Premium (Multifocal, Accommodating, and Extended Depth of Focus), and Phakic), Material (PMMA, Foldable), End User (Hospital, Clinic), and Region - Global Forecast to 2022

The global Intraocular Lens Market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly driven by the growth in the geriatric population and corresponding age-related eye disorders, rising prevalence of eye diseases & diabetes in the overall population across the globe, and increasing government initiatives to control and treat blindness caused by cataract. The key players in the global intraocular lenses market are Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Oculentis GmbH (Germany), NIDEK CO., LTD. (Japan), Aurolab (India), Omni Lens Pvt Ltd. (India), Care Group (India), Hanita Lenses R.C.A Ltd. (Israel), and Fred Hollows Intraocular Laboratory (Eritrea).

January 2018 $ 5650 selected

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

The global autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. The growing incidence of autoimmune diseases along population, technological advancements in analyzing devices, increasing access to medical insurance in the US, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific.(US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad Laboratories. (US), and Abbott (US).

January 2018 $ 5650 selected

Medical Ceramics Market by Type of Material (Bioinert (Zirconia, Alumina), Bioactive (Hydroxyapatite, Glass Ceramics), Bioresorbable, Piezoceramics), Application (Dental, Orthopedic, Cardiovascular, Plastic Surgery), and Region - Global Forecast to 2022

The global medical ceramics market is projected to reach USD 18.45 Billion by 2022 from USD 13.38 Billion in 2017, at a CAGR of 6.6%. The growth of this market is majorly driven by factors such as increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries and wound healing applications, rising number of hip and knee replacement procedures, and increasing demand for implantable devices. Some of the key players in the medical ceramics market are CoorsTek (US), CeramTec (Germany), Kyocera (Japan), Morgan Advance Material (UK), NGK Spark Plug (Japan), DePuy Synthes (US), Zimmer Biomet (US), Rauschert (Germany), Straumann (Switzerland), H.C. Stark (Germany), 3M (US), and DSM (Netherlands).

January 2018 $ 5650 selected

Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

The global vascular grafts market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).

January 2018 $ 5650 selected

Bone Cement & Glue Market by Type (PMMA, Calcium Phosphate, Natural, Synthetic), Application (Arthroplasty (Total Knee, Hip, Shoulder), Kyphoplasty, Vertebroplasty), End User (Hospitals, Clinics, Ambulatory Surgery Centers) - Global Forecast to 2022

The global bone cement and glue market is expected to reach USD 1,322.6 Million by 2022 from USD 993.0 Million in 2017, at a CAGR of 5.9%. The market growth is primarily driven by the growing incidence of sports injuries and increasing developments in regenerative medicine field. Key players in the bone cement and glue market include Stryker (US), Zimmer Biomet (US), DePuy Synthes (US), Smith & Nephew (UK), Arthrex (US), DJO Global (US), Exactech (US), TEKNIMED (France), Heraeus Medical (Germany), CryoLife (US), Cardinal Health (US), and Trimph (Australia).

January 2018 $ 5650 selected

Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023

The global esoteric testing market is projected to reach USD 35.24 Billion by 2023 from USD 20.38 Billion in 2018, at a CAGR of 11.6%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The prominent players in the global esoteric testing market include LabCorp (US), OPKO Health (US), ARUP Laboratories (US), Miraca Holdings (Japan), Myriad Genetics (US), Genomic Health (US), Quest Diagnostics (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics. (US), Invitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US).

January 2018 $ 5650 selected

Antimicrobial Susceptibility Testing Market by Product (Automated System, Disks, MIC Strips, Media), Method (Dilution, Diffusion), Type (Antibacterial, Antifungal), Application (Clinical, Drug Discovery), End User (Labs, Hospitals) - Global Forecast to 2022

The global antimicrobial susceptibility testing market is expected to reach USD 3.47 Billion by 2022 from USD 2.71 Billion in 2017, at a CAGR of 5.1%. Factors such as increasing prevalence of infectious diseases across the globe, emergence of antimicrobial resistance caused due to drug overuse, increasing initiatives by government organizations towards improving the detection and control antimicrobial resistant species, and improving growth opportunities in emerging markets are boosting the demand for antimicrobial susceptibility testing products. As of 2016, some of the major players operating in this market include bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US).

January 2018 $ 5650 selected

Wearable Medical Devices Market by Device (Diagnostic (Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin, Rehabilitation)), Application (Sport, Fitness, RPM), Type (Smartwatch, Patch), Distribution Channel (Pharmacy, Online) - Global Forecast to 2022

The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for wireless connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The wearable medical devices market is highly competitive with several big and small players. Prominent players in this market include Fitbit (US), Philips (Netherlands), LifeWatch (Switzerland), Garmin (Switzerland), and Omron (Japan). The other players operating in this market include Drägerwerk (Germany), Nokia Technologies (US), Jawbone (US), Polar (Finland), Wor(l)d Global Network (US), Activeinsights (UK), VitalConnect (US), Xiaomi (China), Misfit (US), and Monica Healthcare (UK).

January 2018 $ 5650 selected

Ventilator Market by Mobility (Intensive Care, Portable), Type (Adult, Infant), Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End User (Hospital, Home Care, Ambulatory Care Center, EMS) - Global Forecast to 2023

The global ventilators market is projected to reach USD 1,261.9 Million by 2023 from USD 859.9 Million in 2018, at a CAGR of 8.0%. Rapid growth in the geriatric population, increasing incidence of preterm births, and rising number of ICU beds are the major factors driving the growth of the ventilators market. Moreover, the growing investments, favorable regulatory policies, and growth in the healthcare industry in emerging countries in the Asian region are expected to provide favorable growth opportunities for players operating in the ventilators market. The prominent players in the global ventilators market are Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Dräger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand), Air Liquide (France), Zoll Medical (US), Allied Healthcare Products (US), Airon (US), Mindray (China), and Schiller (Switzerland).

January 2018 $ 5650 selected

Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022

Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The global neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US).

January 2018 $ 5650 selected

Nerve Monitoring System Market by Product (Nerve Monitor, Electrode, Probe, Accessories), Technology (EEG, EMG, EP, ECOG), Application (Neurosurgery, ENT Surgery, Spine Surgery, Cardiovascular Surgery), End User (Hospital, ASC) - Global Forecasts to 2022

The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).

January 2018 $ 5650 selected

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022

The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The drug screening market is highly competitive with the presence of several small and big players. Some of the players offering products for drug screening market include Alere (US), Thermo Fisher (US), Siemens Healthineers (US), Alfa Scientific Designs (US), Roche (Switzerland), MPD, Inc. (US), Shimadzu (Japan), OraSure (US), Lifeloc (US), and Drägerwerk (Germany). On the other hand, LabCorp (US), Quest Diagnostics (US), Psychemedics (US), Omega Laboratories (US), CRL (US), SureHire (Canada), and CannAmm (Canada).

January 2018 $ 5650 selected

Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Gastroenterology, Diabetes), End User (Hospital, Home Care) - Global Forecast to 2022

The enteral feeding devices market is expected to reach USD 3.19 Billion by 2022 from USD 2.26 Billion in 2016, at a CAGR of 6.0% during the forecast period. The increasing prevalence of chronic diseases, rising geriatric population, rising incidence of preterm births, growing demand for enteral feeding devices in the home care sector, and the shift from parenteral to enteral nutrition are the major factors driving the growth of the enteral feeding devices market. The prominent players in the enteral feeding devices market are Fresenius Kabi (Germany), Halyard Health (US), Medtronic (Ireland), B. Braun (Germany), Abbott (US), C.R. Bard (US), Boston Scientific (US), Cook Medical (US), CONMED (US), Nestlé (Switzerland), Danone (France), Moog (US), Vygon (France), and Applied Medical Technology (US).

January 2018 $ 5650 selected

Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2022

The global peripheral vascular devices market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 Billion in 2017, at a CAGR of 6.8%. Market growth is primarily driven by the growing incidence of peripheral vascular diseases, growing geriatric population, and increasing preference for minimally invasive surgeries. Key players in the peripheral vascular devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).

January 2018 $ 5650 selected

Cancer/Tumor Profiling Market by Application (Clinical, Research), Technology (Immunoassay, Hybridization (PCR, In Situ Hybridization, DNA/RNA Microarray), NGS, Mass Spectrometry), Cancer Type (Breast, Lung, Prostate, Colorectal) - Global Forecast to 2022

Global cancer/tumor profiling market is projected to reach USD 8.74 Billion in 2022 from USD 5.26 Billion in 2017 at CAGR of 10.7%. Major players operating in the cancer/tumor profiling market include Illumina (US), QIAGEN (Netherlands), NeoGenomics Laboratories (US), HTG Molecular Diagnostic (US), and Genomic Health (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the cancer/tumor profiling market.

January 2018 $ 5650 selected

Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022

The global clinical laboratory services market is projected to reach USD 146.41 Billion by 2022 from USD 113.44 Billion in 2017, at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others

December 2017 $ 5650 selected

Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022

The global amniocentesis needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market.

December 2017 $ 5650 selected

Infection Control Market by Disinfection Products (Disinfectant, Wipes, Sprays, AER, Wraps), Sterilization Products (Steam, Hydrogen Peroxide, Radiation, Indicators, Services), End User (Hospitals, Life Science, Pharmaceuticals) - Global Forecast to 2022

The infection control market is projected to reach USD 21.06 Billion by 2022 from USD 14.40 Billion in 2016, at a CAGR of 6.5% from 2017 to 2022. The growth of the market can be attributed to the factors such as the increasing demand of sterilization and disinfection products among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growing number of surgical procedures, rising focus on food sterilization and disinfection, and the increasing cost burden due to rising geriatric population and incidence of chronic diseases. The key players in the infection control market are STERIS (UK), Getinge (Sweden), Cantel Medical (US), Ecolab (US), 3M (US), Sotera Health (US), Advanced Sterilization Products (US), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (US), Metrex Research (US), Reckitt Benckiser (UK), and Pal Internation (UK).

December 2017 $ 5650 selected

Kidney/Renal Function Test Market by Product (Dipsticks, Reagents, Disposables), Type (Urine Test (Urine Protein, Microalbumin, Creatinine Clearance), Blood Test (Serum Creatinine, BUN)), End User -Global Forecast to 2022

The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).

December 2017 $ 5650 selected

Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022

The global blood glucose monitoring system market was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the blood glucose monitoring system market. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).

December 2017 $ 5650 selected

Optometry/Eye Exam Equipment Market by Type (OCT, Fundus Cameras, Perimeters, Ophthalmoscope, Ultrasound, Autorefractor, Slit Lamp, Corneal Topography, Lensmeter, Chart Projectors, Wavefront Analyzer), End User (Hospital, Clinic) - Global Forecast to 2022

The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0% during the forecast period. Growth in this market can primarily be attributed to the rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes. The prominent players in the global eye exam equipment market are Carl Ziess (Germany), Haag-Streit (Switzerland), Topcon (Japan), NIDEK (Japan), Heidelberg Engineering (Germany), Escalon (US), Novartis (Switzerland), Valent (Canada), Canon (Japan), Essilor (France), Heine Optotechnik (Germany), and Luneau Technology (France).

December 2017 $ 5650 selected

EMS Products Market by Type (Laryngoscope, ET Tube, ECG, Pulse Oximeter, EEG, ICP, TCD, Temperature and Pre-Natal Monitors, Disinfectant, Dressing, Suture, Staple, Wheelchair, Beds), Application (Cardiac, Trauma), End User - Global Forecast to 2022

The global emergency medical service (EMS) products market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US).

December 2017 $ 5650 selected

Stoma/Ostomy Care Market by Product (Bags (Surgery Type (Ileostomy, Colostomy, Urostomy), System (One, Two-Piece), Usability (Drainable, Closed), Shape (Flat, Convex)), and Accessories (Powder, Paste)), End User (Home, Hospital) - Global Forecast to 2022

The global ostomy care market is projected to reach USD 2.99 Billion by 2022 from USD 2.40 Billion in 2017, at a CAGR of 4.5% during the forecast period. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of the ostomy market. The major players in the ostomy care market are ConvaTec (UK), Coloplast (Denmark), Hollister Incorporated (US), B. Braun (Germany), Alcare (Japan), Nu-Hope (US), Marlen (US), Welland Medical (UK), BAO-Health (China), Flexicare Medical (UK), Cymed (US), Schena Ostomy (US), Perma-Type (US), 3M (US), and Smith & Nephew (UK).

December 2017 $ 6780 selected

Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. The gastrointestinal stents market is expected to reach USD 452.6 Million by 2022 from USD 337.5 Million in 2016, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The prominent players in the global gastrointestinal stents market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).

December 2017 $ 5650 selected

Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022

The global endoscopy equipment market was valued at USD 24.32 Billion in 2016 and is projected to reach USD 34.82 Billion by 2022, at a CAGR of 6.4% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. The key players in the global endoscopy equipment market are Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm (Japan), Medtronic (Ireland), Hoya (Japan), CONMED (US), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), Cogentix Medical (US), and B. Braun (Germany).

December 2017 $ 7150 selected

Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022

The global interventional cardiology devices market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices. Key players in the interventional cardiology devices market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).

December 2017 $ 5650 selected

OTC Braces & Support Market by Product (Knee, Back, Spine, Hip, Ankle, Foot, Shoulder, Elbow, Hand), Application (Osteoarthritis, Preventive Care, Ligament Injury), Sales Channel (Pharmacies, Retailers, E-Commerce, Hospitals) - Global Forecasts to 2022

The global OTC braces and supports market is projected to reach USD 1.42 Billion by 2022 from USD 1.10 Billion in 2017, at a CAGR of 5.2%. Factors such as growing prevalence of musculoskeletal disorders and diseases, rapid growth in the geriatric population, rising number of sports-related injuries, and growing adoption of e-commerce platforms for OTC orthopedic braces are driving the growth of the market. As of 2016, key players in this market are DJO Finance LLC (US), Breg, Inc. (US), Ossur Hf (Iceland), DeRoyal Industries, Inc. (US), and Bauerfeind AG (Germany). Other important players in this market include Otto Bock HealthCare (Germany), BSN Medical (Germany), medi GmbH & Co. KG (Germany), 3M Company (US), and THUASNE Group (France), among others.

December 2017 $ 5650 selected

Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022

The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).

November 2017 $ 5650 selected

Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) - Global Forecast to 2022

The blood warmer devices market is expected to reach USD 225.6 Million by 2022 from USD 138.7 Million in 2016 at a CAGR of 8.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Key players in the tissue diagnostics market include 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US).

November 2017 $ 5650 selected

Airway Stent / Lung Stent Market by Type (Tracheal, Laryngeal), Product (Self expandable, Balloon expandable), Material (Metal (Nitinol, Stainless Steel) Silicone, Hybrid), Procedure (Bronchoscopy (Rigid, Flexible), Laryngoscopy) - Global Forecast to 2022

The lung stents market is expected to reach USD 105.6 Million by 2022 from an estimated USD 76.3 Million in 2017, at a CAGR of 6.7%. The rapidly increasing geriatric population, rising preference for minimally invasive procedures, high prevalence of tobacco smoking, and rising prevalence of lung cancer and other respiratory diseases are the major factors driving the growth of the lung stents market. The prominent players in the global lung stents market are Boston Scientific (US), C.R. Bard (US), Teleflex (US), Cook Group (US), Merit Medical Systems (US), Novatech (France), Fuji Systems (Japan), Taewoong Medical (South Korea), ENDO-FLEX (Germany), M.I.Tech (South Korea), Micro-Tech (Nanjing) (China), EFER ENDOSCOPY (France), Hood Laboratories (US), S&G BIOTECH (South Korea), Changzhou Health Microport Medical Device (China), and Kapitex Healthcare (UK).

November 2017 $ 5650 selected

Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022

The global contrast media/contrast agents market is projected to reach USD 5.53 Billion by 2022 from an estimated USD 4.57 Billion in 2017, growing at a CAGR of 3.9% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and growing number of public and private diagnostic centers. The prominent players in the global contrast media market include GE Healthcare (US), Bracco Imaging (Italy), Bayer (Germany), and Guerbet (France) are the major players operating in the market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).

November 2017 $ 5650 selected

Thawing System Market by Type (Manual, Automated), Sample (Blood, Plasma, RBC, Platelets, Whole Blood, Embryo, Semen), End User (Blood Bank, Transfusion Center, Hospital, Tissue Bank, Biotechnology & Pharmaceutical) - Global Forecast to 2022

The thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes. Key players in the thawing system market include Helmer Scientific (US), Boekel Scientific (US), Sarstedt (Germany), Barkey (Germany), BioCision (US), Cardinal Health (US), Sartorius (Germany), GE Healthcare (US), Thermo Fisher Scientific (US), and CytoTherm (US).

November 2017 $ 5650 selected

Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2022

The global urology devices market is expected to reach USD 44.37 Billion by 2022 from USD 31.44 Billion in 2017, at a CAGR of 7.1%. The growing incidence of urological cancer along with a rapidly aging population, technological advancements in urology devices, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the urology devices market include Fresenius Medical Care (Germany), Baxter (US), Boston Scientific (US), Olympus (Japan), Richard Wolf (US), KARL STORZ (Germany), Cook Medical (US), Medtronic (US), C. R. Bard (US), Dornier MedTech (Germany), Prometheus Group (US), Medi-Globe (US), Intuitive Surgical (US), Merit Medical Systems (US), Siemens Healthcare (Germany), Stryker (US), ROCAMED (France), Medica (Italy), NOVAmedtek (Turkey), SRS Medical Systems (US), ProSurg (US), Albyn Medical (UK), EMD Medical Technologies (Canada), and Biolitec (Germany).

November 2017 $ 5650 selected

Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022

Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products. The key players in the global blood collection market are BD (US), Medtronic (US), and Terumo (Japan). Some of the other players operating in this market are Haemonetics (US), Fresenius (Germany) Nipro Medical (US), Kawasumi Laboratories (Japan), F.L. Medical (Italy), Greiner Holding (Austria), and Grifols (Spain).

November 2017 $ 5650 selected

Surgical Imaging Market by Technology (Image Intensifier C-arms, Flat Panel Detector C-arms (FPD C-arms)), Application (Orthopaedic & Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries), and Region - Global Forecasts to 2022

The global surgical imaging market is projected to reach USD 1.63 Billion by 2022 from USD 1.25 Billion in 2017, at a CAGR of 5.5% during the forecast period. The growth of this market is majorly driven by factors such as technological advancements in C-arms, increasing demand for minimally invasive procedures, rising geriatric population, and growing chronic disease prevalence. GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the surgical imaging market. Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India).

November 2017 $ 5650 selected

Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022

The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 239.30 Billion in 2017, at a CAGR of 8.8%. The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. The home healthcare market is highly competitive with the presence of several small and big players. Prominent players in the home healthcare market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), and Roche (Switzerland).

November 2017 $ 5650 selected

Nerve Repair and Regeneration Market by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), - Global Forecast to 2022

The nerve repair and regeneration market is expected to reach USD 10.59 Billion from USD 5.13 Billion in 2016, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, rising geriatric population, and technological advancements are contributing to the growth of this market. Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

November 2017 $ 5650 selected

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022

The global tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 6.9%. The growing incidence of cancer along with a rapidly aging population, technological advancements in tissue diagnostics techniques, and increasing healthcare expenditure are key factors driving the growth of this market. Key players in the tissue diagnostics market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).

November 2017 $ 5650 selected

Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022

The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market. Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

November 2017 $ 5650 selected

US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) - Forecast to 2022

The US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. The US anticoagulation therapy market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.

November 2017 $ 5650 selected

Hearing Aids Market by Product (Receiver In The Ear, Behind The Ear, In The Ear, In The Canal Hearing Aids, Cochlear Implant, BAHA implant), Types of Hearing Loss (Sensorineural, Conductive Hearing loss) & Patient (Adult, Pediatric) - Forecast to 2022

The global hearing aids market is projected to reach USD 9.78 Billion by 2022 from USD 6.97 Billion in 2017, at a CAGR of 7.0%. Factors such as high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids are driving the global hearing aids market. The hearing aids market is dominated by big players such as Sonova (Switzerland), William Demant (Denmark), and GN Store Nord (Denmark) with the presence of several small players as well. Some of the players operating in this market include Cochlear (Australia), Starkey (US), Widex (Denmark), MED-EL (Austria), SeboTek Hearing Systems (US), Audina Hearing Instruments (US), RION (Japan), Horentek (Italy), Microson (Spain), and Arphi Electronics (India).

November 2017 $ 5650 selected

Intravascular Temperature Management Market by Type (Warming, Cooling), Application (Perioperative, Post-operative, Acute Care), Medical Condition (Stroke, Cardiac Arrest, Traumatic Brain Injury (TBI), Myocardial Infarction) - Global Forecasts to 2022

The global intravascular temperature management market is projected to reach USD 272.3 Million by 2022 from USD 219.8 Million in 2016, growing at a CAGR of 3.6%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. Key players in the intravascular temperature management market include 3M (US), Smiths (UK), ZOLL Medical (US), The 37Company (Netherlands), Belmont Instrument (US), Biegler (Austria), Stihler Electronic (Germany), and BD company (US).

November 2017 $ 18000 selected

Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022

The global advanced wound care market is expected to reach USD 13.07 Billion by 2022 from USD 10.43 Billion in 2017, at a CAGR of 4.6%. The market growth is primarily driven by the rising incidence and prevalence of diabetes, growth in geriatric population, increasing prevalence of wound ulcers, technological advancements in advanced wound care products, increasing funding for wound care research, and growing awareness programs about wound management. The key players in the advanced wound care market are Smith & Nephew (UK), Mölnlycke Health Care (Sweden), B. Braun (Germany), ConvaTec Group (US), Coloplast (Denmark), Integra LifeSciences(US), 3M Company (US), Cardinal Health (US), Acelity L.P. (US), Medtronic (US), MPM Medical (US), PAUL HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advanced Medical Solutions Group (UK), BSN medical GmbH (Germany), Wound Care Technologies (US), Vivostat A/S (Denmark), Organogenesis (US), Hematris Wound Care (Germany), Alliqua BioMedical (UK), MiMedX Group (US), Triage Meditech (India), DeRoyal Industries (US), and Laboratoires URGO (UK).

November 2017 $ 5650 selected



3

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us


Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support



US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support


Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo